Description
Alteraciones extrapiramidales
PRINCIPIO ACTIVO: ITRACONAZOL
Vía de Administración:
DOSIS: 50/500 MCG
PRINCIPIO ACTIVO: PAROXETINA CLORHIDRATO
ESMISEN TAB C30 SUBCITRATO DE BISMUTO Alteraciones extrapiramidalesPRINCIPIO ACTIVO: COMPLEJO B KETOROLACO FORMA FARMACUTICA: 30 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
